At-Home Testosterone Testing Industry
Finger-Prick, Saliva, and Mail-In Hormone Panels (Hone, LetsGetChecked, Everlywell, Marek partner labs)
Evidence grade 3 of 5, Mixed. Read how the Atlas grades evidence.
The written rationale for this grade is still being prepared.
- FDA
- Labs operate under CLIA; collection kits are not FDA-approved therapeutics
Reference only. Not medical advice.
What can go wrong
A single low or borderline reading does not establish hypogonadism; the Endocrine Society 2018 guideline requires a repeat morning serum total testosterone before diagnosis. Finger-prick dried-blood-spot and especially saliva testosterone assays vary in accuracy versus venous serum and are not the basis of major-society diagnostic thresholds. Self-interpretation without clinical correlation can drive unnecessary lifelong therapy.
This is something to take to a clinician. The Atlas can tell you what is known about at-home testosterone testing industry in general. It cannot tell you what is happening in your body, and the difference matters most for exactly the symptoms that bring people to this page.
At-home testosterone testing lets a man order a hormone panel online and collect a sample himself, typically by finger-prick dried-blood-spot, saliva, or a self-arranged venous draw. The structural conflict is that several of the most heavily marketed testers - notably Hone Health and Marek Health - also sell or facilitate the testosterone therapy a low result would justify. Everlywell and LetsGetChecked sell testing without an in-house therapy arm, which is a meaningfully different incentive structure. According to the Endocrine Society 2018 guideline, testosterone diagnosis requires a morning serum measurement repeated on a separate day, a standard most single-sample home kits do not meet.
The front door to the funnel: a cheap kit that ends in a prescription.
What people take it for
These are the reasons people give for taking it. They are not effects it has been shown to have.
How it is supposed to work
A consumer buys a panel online; a network physician signs the requisition to satisfy lab-order rules; the sample is self-collected (finger-prick card, saliva tube, or mailed kit) or drawn by mobile/partner phlebotomy; results return through a portal in days. The interpretation step is where vertically integrated platforms route the user toward a coaching or prescribing relationship.
Why a tester that also sells TRT is conflicted
Hone Health markets a finger-prick assessment and then offers, where it deems appropriate, prescription testosterone therapy through affiliated clinicians. Marek Health markets lab panels (often via LabCorp draws) alongside provider coaching that frequently lands on hormone optimization. When the same entity profits from both the test and the treatment, a mid-normal result can be framed as 'suboptimal,' converting a lab sale into a therapy lead. Everlywell and LetsGetChecked, by contrast, sell the test and refer out, so their revenue does not depend on you starting TRT.
What people get wrong
Often saidA home finger-prick T result is as good as a lab draw
ActuallyMethod matters. Major-society reference ranges are built on venous serum measured by validated assays. Finger-prick and saliva results are not interchangeable with those thresholds, and a single random sample ignores timing, fasting, and biological variability.
Often saidIf the kit says you're low, you're low
ActuallyA low screening value is a signal to confirm with a repeat morning serum draw, not a diagnosis. Regression to the mean means many 'low' single readings rise on retest.
Who profits, and who pushes back
Endocrine Society
Diagnosis should rest on symptoms plus unequivocally and consistently low morning serum testosterone, confirmed on a separate day.
Bradley Anawalt, MD
A single low testosterone level, especially from a non-standard sample, is one of the most over-acted-upon numbers in men's health.
Revenue accrues to the kit seller, the processing lab, and - for vertically integrated brands - the downstream therapy and refill business. The most durable margin is the recurring monitoring-plus-prescription relationship a low result creates.
What we do not know
- How often do home-kit 'low' readings normalize on a confirmatory venous morning draw?
- What share of at-home testers who are vertically integrated convert users to therapy versus those that refer out?
At a glance
- Common methods
- Finger-prick dried blood spot, saliva, mail-in serum, mobile phlebotomy
- Typical single-T price
- ~$30-$70; full panels $100-$450+
- Regulation
- CLIA-certified processing labs
- Core conflict
- Tester sometimes also sells the TRT
What this entry does not yet cover
What follows is unfinished work on our side, not a finding about At-Home Testosterone Testing Industry. A short entry is not a safe entry.
- Timeline. We have not built the dated record of research and regulatory events.
- Cost and market. We have not documented what it sells for or who sells it.
- Supply chain. We have not mapped where it is made.
- Who uses it. We have not documented the user groups.
- What could change. No forward-looking summary yet.
- How it compares. We have not set it against the alternatives.
- Children and teenagers. We have not checked what is known about younger people.
Sources
No sources recorded for this entry yet. Nothing on this page can be checked against a citation until that changes, so treat it as a summary awaiting its evidence.